Psyllium husk

What it is

Psyllium husk is the outer coating of the seeds of Plantago ovata. It is an indigestible fibre that absorbs water and swells into a gel. It is sold as a bulk laxative and as a fibre supplement.

What the research says

Psyllium has one of the stronger evidence bases among fibre supplements for lowering LDL cholesterol. A 21-trial meta-analysis found reductions that grew with dose. Its value for weight loss is not supported: a 2025 meta-analysis found no fall in BMI or waist size. Harms include choking and blockage of the oesophagus if it swells before reaching the stomach, work-related allergy and asthma in healthcare staff who prepare it, and reduced absorption of some medicines taken at the same time.

Evidence grade: Well established.

What goes wrong

Case report: a 76-year-old man with Parkinson's disease developed acute oesophageal obstruction from a psyllium bezoar about 10 hours after taking psyllium powder; it was removed endoscopically. (Source 1)

• Case report, Very low certainty.
• Size: 1 patient.
• Who: 76-year-old man with Parkinson's disease.
• How long: Single ingestion.
• Result: 2.0 cm x 2.5 cm mass near the gastro-oesophageal junction causing severe dysphagia.
• Funding: Not stated in the text we read.

Limit of this finding: The authors suggest the man's Parkinson's disease, which can slow the movement of food down the oesophagus, may have contributed to the blockage. This is a single case. It shows the blockage can happen, not how often it happens, and it does not show the same risk in people without swallowing or oesophageal problems.

A 76-year-old male with Parkinson's disease visited the emergency department with swallowing difficulty approximately 10 h after ingesting psyllium seed husk powder.

The case report's authors describe psyllium husk as able to retain water and expand rapidly, and they conclude that care is needed with bulk laxatives. (Source 2)

• Case report, Very low certainty.
• Size: 1 patient plus discussion of earlier reports.
• Who: Psyllium users.
• How long: Not applicable.
• Result: Mechanism: water retention and rapid expansion.
• Funding: Not stated.

It also has hygroscopic characteristics that allow it to retain water and expand rapidly.

Among staff at four chronic-care hospitals who prepared psyllium for patients, 5% to 12% were IgE-sensitised to psyllium, and 4 of 6 people challenged developed bronchospasm. (Source 3)

• Survey study, Low certainty.
• Size: 193 of 248 workers tested.
• Who: Healthcare workers in chronic-care hospitals.
• How long: Occupational exposure.
• Result: 39% reported symptoms; 3% skin-test positive; 12% raised specific IgE; 4 of 6 bronchospastic reactions on specific inhalation challenge.
• Funding: Not stated in the abstract.

Psyllium is a high molecular weight laxative that can cause occupational asthma among health care workers who prepare this product for chronically ill patients.

A clinical review reports that psyllium can reduce carbamazepine absorption and blood levels, with a case report of reduced lithium absorption. (Source 4)

• Systematic review, Low certainty.
• Size: Narrative review of interaction reports.
• Who: Patients with chronic illnesses taking medicines.
• How long: Not applicable.
• Result: Reduced carbamazepine absorption and serum levels; one case of reduced lithium absorption.
• Funding: Not stated.

Psyllium can reduce carbamazepine (Tegretol) absorption and serum levels. Additionally, there is a case report showing that psyllium decreased the absorption of lithium.

What the evidence supports

In a meta-analysis of 21 placebo-controlled trials, psyllium lowered total and LDL cholesterol in people with mild-to-moderately high cholesterol, and the effect grew with dose. (Source 5)

• Meta-analysis, Moderate certainty.
• Size: 1030 psyllium and 687 placebo participants across 21 studies.
• Who: Adults with mild-to-moderate hypercholesterolaemia.
• How long: More than 2 weeks.
• Result: Total cholesterol -0.375 mmol/l (95% CI 0.257-0.494); LDL -0.278 mmol/l (95% CI 0.213-0.312); significant dose-response between 3 and 20.4 g/day.
• Funding: Independent (partly supported by the Cooperative Program of Rhone-Alps Region and Shanghai)

Limit of this finding: The paper reports an LDL cholesterol fall of 0.278 mmol/l with a 95% confidence interval of 0.213 to 0.312. A point estimate normally sits near the middle of its interval, but this one is close to the top, so one of these numbers may be misprinted in the original paper. The direction of the result (LDL lowered compared with placebo) is not in doubt, but treat the exact size of the LDL fall with caution.

Compared with placebo, consumption of psyllium lowered serum total cholesterol by 0.375 mmol/l (95% CI: 0.257–0.494 mmol/l), and LDL cholesterol by 0.278 mmol/l (95% CI: 0.213–0.312 mmol/l).

An umbrella review of 52 meta-analyses (47,197 people), covering all fibre types rather than psyllium alone, found higher fibre intake was associated with lower total and LDL cholesterol but not with changes in triglycerides or HDL. (Source 6)

• Review of reviews, Moderate certainty.
• Size: 52 meta-analyses, 47,197 subjects.
• Who: Adults, mixed.
• How long: Varied.
• Result: All fibre types pooled: LDL-C ES -0.25 (95% CI -0.34 to -0.16, P<0.001); triglycerides and HDL unchanged.
• Funding: Not stated in the text we read.

higher dietary fiber intake was associated with significant reductions in the serum level of total cholesterol (ES=-0.28, 95% CI: -0.39, -0.16, P<0.001) and low-density lipoprotein cholesterol (ES=-0.25, 95% CI: -0.34, -0.16, P<0.001)

Position (US FDA, current regulation): foods may carry a heart-disease health claim for soluble fibre from psyllium husk at 7 g or more per day. (Source 7)

• Official position, Certainty not rated.
• Size: Not applicable.
• Who: US food labelling.
• How long: Not applicable.
• Result: Qualifying intake level set in 21 CFR 101.81.
• Funding: Government.

7 g or more per day of soluble fiber from psyllium seed husk.

What the evidence does not support

Across 27 trials, psyllium did not reduce BMI, waist-to-hip ratio or waist size, and the authors reported that it increased body weight. (Source 8)

• Meta-analysis, Low certainty.
• Size: 27 RCTs in adults.
• Who: Adults.
• How long: Varied.
• Result: Body weight WMD +3.57 (95% CI 1.43 to 5.72); BMI WMD -0.06 (95% CI -0.68 to 0.55, non-significant); WHR -0.10 (non-significant); waist +0.72 (non-significant)
• Funding: Not confirmed. The paper gives an Isfahan University of Medical Sciences ethics approval code and grant number; we did not find a separate funding statement.

However, there was a non-significant decrease in BMI, with a WMD of −0.06 (95% confidence intervals: -0.68, 0.55; p-value > 0.05), and a non-significant decrease in WHR

How much

• Reference intake: No RDA or AI exists for psyllium itself. The US FDA health-claim regulation (21 CFR 101.81, current eCFR) names 7 g or more per day of soluble fibre from psyllium seed husk as the intake linked to reduced heart disease risk for labelling purposes. (Source 7)
• Upper limit: We found no tolerable upper intake level for psyllium in the sources we read. (Source 5)
• Studied: Trials in the Wei meta-analysis gave 3.0 to 20.4 g of psyllium per day for more than 2 weeks. (Source 5)

A common belief, and what the research shows

The belief: Psyllium is a weight-loss fibre.

What the research shows: A 2025 meta-analysis of 27 randomised trials did not find it reduced BMI or waist size: "there was a non-significant decrease in BMI", and the authors concluded "psyllium significantly increased body weight."

Questions and answers

What is it?

Psyllium husk is the seed coating of the Plantago ovata plant. It is an indigestible fibre that forms a gel in water and is used as a laxative and fibre supplement. (Source 2)

What does it do in the body?

It absorbs water and swells into a gel in the gut. It is used for constipation and, in trials, it lowers total and LDL cholesterol in a dose-dependent way. (Source 5)

Is it good or bad for you?

For cholesterol, the evidence is good. Harms are uncommon but real: it can block the oesophagus if it swells too early, especially in people with swallowing problems. Healthcare workers can become allergic from handling it, and it can reduce absorption of some medicines. (Source 4)

How do you get more of it?

Trials gave psyllium as a supplement at 3 to 20.4 g a day. This describes what was studied and is not a recommendation. (Source 5)

If it is harmful, what reduces it?

Psyllium does not build up in the body. When it forms a blockage in the oesophagus, it has been removed by endoscopy. Clinicians advise taking medicines several hours apart from bulk laxatives so the medicine can be absorbed. (Source 4)

Why might someone be low in it or missing it?

Psyllium is not an essential nutrient, so no one is deficient in it. People simply do not get it unless they take it as a supplement or eat foods it has been added to. (Source 1)

Which whole foods contain it or feed it?

Psyllium comes from the seeds of Plantago ovata. In the US it is added to some foods, which may then carry an FDA-authorised heart-health claim. It is not a common part of everyday whole foods. (Source 7)

What happens if you do not have it?

No deficiency disease is described. Without psyllium, people miss out on the modest cholesterol-lowering effect seen in trials. (Source 5)

How can you test for it?

No test measures psyllium status, because it is not a nutrient the body stores. For psyllium allergy, researchers have used skin-prick tests and specific IgE blood tests, and these gave different sensitisation rates (5% by skin testing vs 12% by IgE) in the same workforce. (Source 3)

References

1. World Journal of Clinical Cases. Acute esophageal obstruction after ingestion of psyllium seed husk powder: A case report. 2022. PMID 35321163, DOI 10.12998/wjcc.v10.i7.2336. Read the source
2. World Journal of Clinical Cases. Acute esophageal obstruction after ingestion of psyllium seed husk powder: A case report. 2022. PMID 35321163, DOI 10.12998/wjcc.v10.i7.2336. Read the source
3. The American Review of Respiratory Disease. Prevalence of occupational asthma and immunologic sensitization to psyllium among health personnel in chronic care hospitals. 1990. PMID 2252254, DOI 10.1164/ajrccm/142.6_Pt_1.1359. Read the source
4. American Family Physician. Herbal and Dietary Supplement–Drug Interactions in Patients with Chronic Illnesses. 2008. Read the source
5. European Journal of Clinical Nutrition. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials. 2009. DOI 10.1038/ejcn.2008.49. Read the source
6. Frontiers in Nutrition. Associations between dietary fiber intake and cardiovascular risk factors: An umbrella review of meta-analyses of randomized controlled trials. 2022. DOI 10.3389/fnut.2022.972399. Read the source
7. US Food and Drug Administration (Electronic Code of Federal Regulations). 21 CFR 101.81 Health claims: Soluble fiber from certain foods and risk of coronary heart disease (CHD), paragraph (c)(2)(i)(G). current as of 2026. Read the source
8. Journal of Health, Population and Nutrition. The effect of psyllium consumption on anthropometric indices: a systematic review and dose-response meta-analysis of randomized controlled trials. 2025. DOI 10.1186/s41043-025-01103-x. Read the source